Literature DB >> 20036285

Differences in methodology, but not differences in viral strain, account for variable experimental outcomes in laboratories utilizing the cottontail rabbit papillomavirus model.

Nancy M Cladel1, Jiafen Hu, Karla K Balogh, Neil D Christensen.   

Abstract

The cottontail rabbit papillomavirus (CRPV) animal model is used in several laboratories worldwide to investigate immunogenicity, carcinogenicity and life cycle aspects of papillomaviruses. It is the only animal model in which the full life cycle of the virus from initiation of infection to malignant progression can be studied. A major strength of the model is that the viral DNA is infectious. This feature allows for the study of mutant genomes without the need to create infectious mutant virus. Results from laboratory to laboratory have not always been consistent. Different laboratories use different methods for creating infections from DNA and it was postulated that the different challenge methods could play a role in the differential outcomes. Because different laboratories use different strains of CRPV, it was also desirable to test if the difference in CRPV genomes contributed to the differential outcomes. In this study, three of the CRPV strains used most widely (Washington B, Orth CRPV and Hershey CRPV) were cloned into PUC19; the E8 ATG ko mutants for each strain were also generated. We employed the infection technique reported previously in which scarification is done first and is followed with delivery of DNA by pipette 3 days later. The papilloma outgrowth generated by these three wild type constructs and their E8 ATG ko mutants was compared. No significant difference was found among the three strains or their E8 ATG ko mutants. E8 ATG ko mutants induced significantly smaller but persistent papillomas when compared to their respective wild type CRPVs. The gene gun was also used to create infections with both Hershey CRPV DNA and the corresponding E8 ATG ko and was found to lead to less vigorous growth as well as some regressions. Further studies suggested that gene gun delivery might have induced an immune response which then resulted in compromised growth of papillomas. It was concluded that the E8 gene is not required for infection. We suggest that standardized infection methods should be used in laboratories so that inconsistencies in conclusions will be minimized. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20036285      PMCID: PMC2845176          DOI: 10.1016/j.jviromet.2009.12.014

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  26 in total

1.  Immunization of rabbits with cottontail rabbit papillomavirus E1 and E2 genes: protective immunity induced by gene gun-mediated intracutaneous delivery but not by intramuscular injection.

Authors:  R Han; C A Reed; N M Cladel; N D Christensen
Journal:  Vaccine       Date:  2000-07-01       Impact factor: 3.641

Review 2.  The rabbit viral skin papillomas and carcinomas: a model for the immunogenetics of HPV-associated carcinogenesis.

Authors:  F Breitburd; J Salmon; G Orth
Journal:  Clin Dermatol       Date:  1997 Mar-Apr       Impact factor: 3.541

3.  Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis.

Authors:  Mathieu Nonnenmacher; Jérôme Salmon; Yves Jacob; Gérard Orth; Françoise Breitburd
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  The inhibitory effects of bryostatin 1 administration on the growth of rabbit papillomas.

Authors:  J M Bodily; D J Hoopes; B L Roeder; S G Gilbert; G R Pettit; C L Herald; D N Rollins; R A Robison
Journal:  Cancer Lett       Date:  1999-02-08       Impact factor: 8.679

5.  Cutaneous antigen priming via gene gun leads to skin-selective Th2 immune-inflammatory responses.

Authors:  David Alvarez; Greg Harder; Ramzi Fattouh; Jiangfeng Sun; Susanna Goncharova; Martin R Stämpfli; Anthony J Coyle; Jonathan L Bramson; Manel Jordana
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 6.  Cottontail rabbit papillomavirus (CRPV) model system to test antiviral and immunotherapeutic strategies.

Authors:  Neil D Christensen
Journal:  Antivir Chem Chemother       Date:  2005

Review 7.  Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.

Authors:  H zur Hausen
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

8.  Protective cell-mediated immunity by DNA vaccination against Papillomavirus L1 capsid protein in the Cottontail Rabbit Papillomavirus model.

Authors:  Jiafen Hu; Nancy M Cladel; Lynn R Budgeon; Cynthia A Reed; Martin D Pickel; Neil D Christensen
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

9.  Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes.

Authors:  R Han; N M Cladel; C A Reed; X Peng; N D Christensen
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

10.  The cottontail rabbit papillomavirus model of high-risk HPV-induced disease.

Authors:  Janet L Brandsma
Journal:  Methods Mol Med       Date:  2005
View more
  5 in total

1.  Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).

Authors:  Aayushi Uberoi; Satoshi Yoshida; Paul F Lambert
Journal:  J Virol Methods       Date:  2017-12-15       Impact factor: 2.014

Review 2.  The rabbit papillomavirus model: a valuable tool to study viral-host interactions.

Authors:  Nancy M Cladel; Xuwen Peng; Neil Christensen; Jiafen Hu
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

3.  Characterization of the nuclear matrix targeting sequence (NMTS) of the BPV1 E8/E2 protein--the shortest known NMTS.

Authors:  Eve Sankovski; Kristiina Karro; Mari Sepp; Reet Kurg; Mart Ustav; Aare Abroi
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

4.  Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models.

Authors:  Nancy M Cladel; Pengfei Jiang; Jingwei J Li; Xuwen Peng; Timothy K Cooper; Vladimir Majerciak; Karla K Balogh; Thomas J Meyer; Sarah A Brendle; Lynn R Budgeon; Debra A Shearer; Regina Munden; Maggie Cam; Raghavan Vallur; Neil D Christensen; Zhi-Ming Zheng; Jiafen Hu
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

Review 5.  Modeling HPV-Associated Disease and Cancer Using the Cottontail Rabbit Papillomavirus.

Authors:  Nancy M Cladel; Jie Xu; Xuwen Peng; Pengfei Jiang; Neil D Christensen; Zhi-Ming Zheng; Jiafen Hu
Journal:  Viruses       Date:  2022-09-04       Impact factor: 5.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.